Valerio Therapeutics
29
0
0
23
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 75/100
20.7%
6 terminated/withdrawn out of 29 trials
79.3%
-7.2% vs industry average
10%
3 trials in Phase 3/4
43%
10 of 23 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (29)
A Phase 1/2 Study of VIO-01 in Participants With Recurrent Solid Tumors
Role: lead
Study to Assess Safety and Efficacy of AsiDNA in Combination with Olaparib in Participants with Recurrent Solid Tumors
Role: lead
AsiDNA (a DNA Repair Inhibitor) Administered IntraVenously in Advanced Solid Tumors
Role: lead
Belinostat in Relapsed or Refractory Peripheral T-Cell Lymphoma
Role: collaborator
Efficacy and Safety Doxorubicin Transdrug Study in Patients Suffering From Advanced Hepatocellular Carcinoma
Role: lead
A Trial of Belinostat in Combination With Erlotinib in Patients With Non-small Cell Lung Cancer
Role: collaborator
MTD Study PXD-101 in Combination With Paclitaxel + Carboplatin in Chemotherapy-Naive Patients With Stage IV NSCLC
Role: collaborator
Efficacy and Safety Study of Clonidine Lauriad® to Treat Oral Mucositis
Role: lead
Phase 1 PK, Bioavailability, Safety Study of Clonidine MBT w Catapres in Healthy Volunteers
Role: lead
A Clinical Trial on Topotect® (Dexrazoxane) in the Treatment of Accidental Extravasation of Anthracyclines
Role: lead
Efficacy of TopotectTM (Dexrazoxane) for Accidental Extravasation of Anthracyclines
Role: lead
A Study to Assess APO866 for the Treatment of Advanced Melanoma
Role: lead
A Phase I/II Study to Assess the Safety and Tolerability of APO866 for the Treatment of Refractory B-CLL
Role: lead
A Study of Belinostat in Combination With Warfarin in Patients With Solid Tumors or Hematological Malignancies
Role: collaborator
A Phase I Dose Finding Study of APO010 in Patients With Solid Tumors
Role: lead
Safety and Efficacy Study of Electrotransfer of Plasmid AMEP to Treat Advanced or Metastatic Melanoma
Role: lead
Safety and Efficacy of Intramuscular Electrotransfer of Plasmid AMEP in Patients Suffering From Advanced or Metastatic Melanoma
Role: lead
Trial of PXD101 (Belinostat) in Combination With Idarubicin to Treat AML Not Suitable for Standard Intensive Therapy
Role: lead
A Phase II Clinical Trial of PXD101 in Patients With Recurrent or Refractory Cutaneous and Peripheral T-Cell Lymphomas
Role: lead
Belinostat, Carboplatin and Paclitaxel (BelCaP) Compared to Carboplatin and Paclitaxel in Patients With Cancer of Unknown Primary
Role: lead